A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

April 7, 2025

Primary Completion Date

May 1, 2028

Study Completion Date

December 31, 2028

Conditions
Breast NeoplasmsQuality of Life (QOL)ToxicitiesBreast Diseases
Interventions
PROCEDURE

blood sampling

At baseline, participants will undergo peripheral blood collection using EDTA tubes. A total of 10 mL of venous blood will be collected and processed into plasma and peripheral blood mononuclear cells (PBMCs). Plasma samples will be stored at -80°C, and PBMCs will be cryopreserved in liquid nitrogen. These samples will be used for future biomarker discovery, multi-omics analysis, and studies of biological mechanisms underlying treatment-related toxicities.

Trial Locations (3)

100021

RECRUITING

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

518116

ACTIVE_NOT_RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen

030013

ACTIVE_NOT_RECRUITING

Shanxi Cancer Hospital, Taiyuan

All Listed Sponsors
lead

FangYi

OTHER